0000075252 false 0000075252 2026-05-11 2026-05-11

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 11, 2026

Accendra Health, Inc.

(Exact name of registrant as specified in its charter)

​

​ | ​ | ​ | ​
Virginia | 001-09810 | ​ | 54-1701843
(State or other jurisdiction of | (Commission | ​ | (I.R.S. Employer
incorporation or organization) | File Number) | ​ | Identification No.)
​ | ​ | ​ | ​
4435 Waterfront Drive, Suite 300 Glen Allen, Virginia | ​ | ​ | 23060
(Address of principal executive | ​ | ​ | ​
offices) | ​ | ​ | (Zip Code)
​ | ​ | ​ | ​
Post Office Box 27626, | ​ | ​ | ​
Richmond, Virginia | ​ | ​ | 23261-7626
(Mailing address of principal | ​ | ​ | ​
executive offices) | ​ | ​ | (Zip Code)

​

Registrant’s telephone number, including area code (804) 277-4304

​

10900 Nuckols Road, Suite 400, Glen Allen, Virginia, 23060

(Former name, former address and former fiscal year, if changes since last report)

Securities registered pursuant to Section 12(b) of the Act:

​

​ | ​ | ​ | ​ | ​
Title of each class | ​ ​ ​ | Trading Symbol(s) | ​ ​ ​ | Name of each exchange on which registered
Common Stock, $2 par value per share | ​ | ACH | ​ | New York Stock Exchange

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

​

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

​

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

​

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

​

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

​

​

​

Item 2.02Results of Operations and Financial Condition.

On May 11, 2026, Accendra Health, Inc. (the “Company”) issued a press release regarding its financial results for the first quarter ended March 31, 2026. The Company is furnishing the press release attached hereto as Exhibit 99.1 pursuant to Item 2.02 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 7.01Regulation FD Disclosure.

On May 11, 2026, the Company posted an earnings presentation on the Investor Relations section of its website. The Company is furnishing the earnings presentation attached hereto as Exhibits 99.2 pursuant to Item 7.01 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.2, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01Financial Statements and Exhibits.

(d)Exhibits.

99.1 | ​ ​ ​ | Press Release issued by the Company on May 11, 2026, announcing first quarter results (furnished pursuant to Item 2.02)
99.2 | ​ | Earnings Presentation dated May 11, 2026 (furnished pursuant to Item 7.01)
104 | ​ | Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document)

​

​

​

​

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

​

​

​ | ​ | ​ | ​
​ | OWENS & MINOR, INC. |
​ | ​ |
Date: May 11, 2026 | By: | /s/ Heath H. Galloway |
​ | Name: | ​ | Heath H. Galloway
​ | Title: | ​ | Executive Vice President, General Counsel and Corporate Secretary

​

​

​

​